Grant - Surf Bio

Grant - Surf Bio

Investment Firm

Overview

Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

Announced Date

Apr 30, 2024

Funding Type

Grant

Highlights

Location

United States, North America

Social

Investor Lead

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation is a early_stage_venture and grant and late_stage_venture firm.

Participant Investors

1

Investor Name
Participant InvestorBill & Melinda Gates Foundation

Round Details and Background

Surf Bio raised $1600000 on 2024-04-30 in Grant

Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 12, 2022
Seed Round - Surf Bio
2-16.0M
Apr 30, 2024
Grant - Surf Bio
1-1.6M